<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1 — aet03_1 • chevron</title>


<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous" />


<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1 — aet03_1" />
<meta property="og:description" content="An adverse events table categorized by System Organ Class, Dictionary-Derived Term  and Greatest intensity." />




<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body data-spy="scroll" data-target="#toc">
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">chevron</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">0.1.0.9000</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fas fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li>
  <a href="../articles/index.html">Articles</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
<!-- start_releases -->
<li class="dropdown">
	<a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
Other releases
<span class="caret"></span></a><ul class="dropdown-menu" role="menu">
   <li><a href="../index.html">latest</a></li>
   <li><a href="..//index.html"></a></li>
</ul></li>
<!-- end_releases -->
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/insightsengineering/chevron">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1</h1>
    
    <div class="hidden name"><code>aet03_1.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>An adverse events table categorized by System Organ Class, Dictionary-Derived Term  and Greatest intensity.</p>
    </div>

    <pre class="usage"><span class='fu'>aet03_1</span><span class='op'>(</span>
  <span class='va'>adam_db</span>,
  armvar <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>armvar</span>,
  prune_0 <span class='op'>=</span> <span class='cn'>TRUE</span>,
  lbl_overall <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>lbl_overall</span>,
  deco <span class='op'>=</span> <span class='fu'><a href='std_deco.html'>std_deco</a></span><span class='op'>(</span><span class='st'>"AET03"</span><span class='op'>)</span>,
  .study <span class='op'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/list.html'>list</a></span><span class='op'>(</span>armvar <span class='op'>=</span> <span class='st'>"ACTARM"</span>, lbl_overall <span class='op'>=</span> <span class='cn'>NULL</span><span class='op'>)</span>
<span class='op'>)</span>

<span class='fu'>aet03_1_lyt</span><span class='op'>(</span>
  armvar <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>armvar</span>,
  lbl_AEBODSYS <span class='op'>=</span> <span class='st'>""</span>,
  lbl_AEDECOD <span class='op'>=</span> <span class='st'>""</span>,
  severity_grade <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>severity_grade</span>,
  lbl_overall <span class='op'>=</span> <span class='va'>.study</span><span class='op'>$</span><span class='va'>lbl_overall</span>,
  deco <span class='op'>=</span> <span class='fu'><a href='std_deco.html'>std_deco</a></span><span class='op'>(</span><span class='st'>"AET03"</span><span class='op'>)</span>,
  .study <span class='op'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/list.html'>list</a></span><span class='op'>(</span>armvar <span class='op'>=</span> <span class='st'>"ACTARM"</span>, lbl_overall <span class='op'>=</span> <span class='cn'>NULL</span>, severity_grade <span class='op'>=</span> <span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='st'>"MILD"</span>,
    <span class='st'>"MODERATE"</span>, <span class='st'>"SEVERE"</span>, <span class='st'>"LIFE THREATENING"</span><span class='op'>)</span><span class='op'>)</span>
<span class='op'>)</span></pre>

    <h2 class="hasAnchor" id="arguments"><a class="anchor" href="#arguments"></a>Arguments</h2>
    <table class="ref-arguments">
    <colgroup><col class="name" /><col class="desc" /></colgroup>
    <tr>
      <th>adam_db</th>
      <td><p>(<code>dm</code>) object containing the ADaM datasets</p></td>
    </tr>
    <tr>
      <th>armvar</th>
      <td><p>(<code>character</code>) variable used for column splitting</p></td>
    </tr>
    <tr>
      <th>prune_0</th>
      <td><p>(<code>logical</code>) remove 0 count rows</p></td>
    </tr>
    <tr>
      <th>lbl_overall</th>
      <td><p>(<code>character</code>) label used for overall column, if set to <code>NULL</code> the overall column is omitted</p></td>
    </tr>
    <tr>
      <th>deco</th>
      <td><p>(<code>character</code>) decoration with <code>title</code>, <code>subtitles</code> and <code>main_footer</code> content</p></td>
    </tr>
    <tr>
      <th>.study</th>
      <td><p>(<code>list</code>)  with default values for the arguments of the function</p></td>
    </tr>
    <tr>
      <th>lbl_AEBODSYS</th>
      <td><p>(<code>string</code>) text label for AEBODSYS.</p></td>
    </tr>
    <tr>
      <th>lbl_AEDECOD</th>
      <td><p>(<code>string</code>) text label for AEDECOD.</p></td>
    </tr>
    <tr>
      <th>severity_grade</th>
      <td><p>(<code>vector of strings</code>) describing the severity levels present in the data set.</p></td>
    </tr>
    </table>

    <h2 class="hasAnchor" id="details"><a class="anchor" href="#details"></a>Details</h2>

    
<ul>
<li><p>Default Adverse Events by Greatest Intensity table</p></li>
<li><p>Numbers represent absolute numbers of patients and fraction of <code>N</code></p></li>
<li><p>Remove zero-count rows unless overridden with <code>prune_0 = FALSE</code>.</p></li>
<li><p>Split columns by arm</p></li>
<li><p>Does not include a total column by default</p></li>
<li><p>Sort by Body System or Organ Class (SOC) and Dictionary-Derived Term (PT)</p></li>
</ul>

    <h2 class="hasAnchor" id="functions"><a class="anchor" href="#functions"></a>Functions</h2>

    
<ul>
<li><p><code>aet03_1_lyt</code>:</p></li>
</ul>

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><span class='r-in'></span>
<span class='r-in'><span class='kw'><a href='https://rdrr.io/r/base/library.html'>library</a></span><span class='op'>(</span><span class='va'><a href='https://cynkra.github.io/dm/'>dm</a></span><span class='op'>)</span></span>
<span class='r-in'><span class='kw'><a href='https://rdrr.io/r/base/library.html'>library</a></span><span class='op'>(</span><span class='va'><a href='https://github.com/roche/rtables'>rtables</a></span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='va'>db</span> <span class='op'>&lt;-</span> <span class='fu'><a href='syn_test_data.html'>syn_test_data</a></span><span class='op'>(</span><span class='op'>)</span> <span class='op'><a href='https://magrittr.tidyverse.org/reference/pipe.html'>%&gt;%</a></span></span>
<span class='r-in'>  <span class='fu'><a href='preprocess_data.html'>preprocess_data</a></span><span class='op'>(</span><span class='st'>"aet03_1"</span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='fu'>aet03_1</span><span class='op'>(</span><span class='va'>db</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Adverse Events by Greatest Intensity: {Specify Population}</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Protocol: {{protocol}}, Snapshot: {{snapshot}}, Snapshot Date: {{snapshot-date}}, Cutoff Date: {{cutoff-date}}</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ————————————————————————————————————————————————————————————————————</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> MedDRA System Organ Class   A: Drug X    B: Placebo   C: Combination</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MedDRA Preferred Term       (N=97)      (N=103)        (N=102)    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ————————————————————————————————————————————————————————————————————</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> - Any Intensity -           97 (100%)    103 (100%)     102 (100%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> MILD                         5 (5.2%)     6 (5.8%)       4 (3.9%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> MODERATE                    19 (19.6%)   23 (22.3%)     20 (19.6%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> SEVERE                      73 (75.3%)   74 (71.8%)     78 (76.5%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl A.1                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         62 (63.9%)   64 (62.1%)     77 (75.5%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MILD                      25 (25.8%)   20 (19.4%)     34 (33.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  37 (38.1%)   44 (42.7%)     43 (42.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd A.1.1.1.1                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       42 (43.3%)    36 (35%)      54 (52.9%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MILD                    42 (43.3%)    36 (35%)      54 (52.9%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd A.1.1.1.2                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       37 (38.1%)   44 (42.7%)     43 (42.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                37 (38.1%)   44 (42.7%)     43 (42.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl B.2                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         59 (60.8%)   59 (57.3%)     73 (71.6%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MILD                      23 (23.7%)   22 (21.4%)     28 (27.5%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  36 (37.1%)   37 (35.9%)     45 (44.1%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd B.2.2.3.1                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       38 (39.2%)   42 (40.8%)     42 (41.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MILD                    38 (39.2%)   42 (40.8%)     42 (41.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd B.2.1.2.1                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       36 (37.1%)   37 (35.9%)     45 (44.1%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                36 (37.1%)   37 (35.9%)     45 (44.1%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl D.1                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         60 (61.9%)   56 (54.4%)     67 (65.7%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  20 (20.6%)   24 (23.3%)     24 (23.5%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   SEVERE                    40 (41.2%)   32 (31.1%)     43 (42.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd D.1.1.1.1                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       40 (41.2%)   32 (31.1%)     43 (42.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     SEVERE                  40 (41.2%)   32 (31.1%)     43 (42.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd D.1.1.4.2                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       37 (38.1%)   37 (35.9%)     41 (40.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                37 (38.1%)   37 (35.9%)     41 (40.2%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl D.2                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         35 (36.1%)   50 (48.5%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MILD                      35 (36.1%)   50 (48.5%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd D.2.1.5.3                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       35 (36.1%)   50 (48.5%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MILD                    35 (36.1%)   50 (48.5%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl B.1                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         37 (38.1%)   40 (38.8%)     36 (35.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   SEVERE                    37 (38.1%)   40 (38.8%)     36 (35.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd B.1.1.1.1                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       37 (38.1%)   40 (38.8%)     36 (35.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     SEVERE                  37 (38.1%)   40 (38.8%)     36 (35.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl C.2                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         26 (26.8%)   38 (36.9%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  26 (26.8%)   38 (36.9%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd C.2.1.2.1                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       26 (26.8%)   38 (36.9%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                26 (26.8%)   38 (36.9%)      49 (48%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl C.1                                                              </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -          32 (33%)    38 (36.9%)     35 (34.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   SEVERE                     32 (33%)    38 (36.9%)     35 (34.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd C.1.1.1.3                                                     </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -        32 (33%)    38 (36.9%)     35 (34.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     SEVERE                   32 (33%)    38 (36.9%)     35 (34.3%)  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ————————————————————————————————————————————————————————————————————</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Investigator text for AEs encoded using MedDRA version xx.x.  All counts represent patients. Multiple occurrences of the same AE in one individual are counted once at the greatest intensity for this preferred term. To the SOC Overall row counts, a patient contributes only with the AE occuring with the greatest intensity within the SOC. Standard footnote defining AEs included in table (e.g., includes AEs with onset from first dose of study drug through 7 days after last dose of study drug).</span>
<span class='r-in'><span class='fu'>aet03_1</span><span class='op'>(</span><span class='va'>db</span>, lbl_overall <span class='op'>=</span> <span class='st'>"All Patients"</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Adverse Events by Greatest Intensity: {Specify Population}</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Protocol: {{protocol}}, Snapshot: {{snapshot}}, Snapshot Date: {{snapshot-date}}, Cutoff Date: {{cutoff-date}}</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ———————————————————————————————————————————————————————————————————————————————————</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> MedDRA System Organ Class   A: Drug X    B: Placebo   C: Combination   All Patients</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MedDRA Preferred Term       (N=97)      (N=103)        (N=102)         (N=302)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ———————————————————————————————————————————————————————————————————————————————————</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> - Any Intensity -           97 (100%)    103 (100%)     102 (100%)      302 (100%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> MILD                         5 (5.2%)     6 (5.8%)       4 (3.9%)        15 (5%)   </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> MODERATE                    19 (19.6%)   23 (22.3%)     20 (19.6%)      62 (20.5%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> SEVERE                      73 (75.3%)   74 (71.8%)     78 (76.5%)     225 (74.5%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl A.1                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         62 (63.9%)   64 (62.1%)     77 (75.5%)     203 (67.2%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MILD                      25 (25.8%)   20 (19.4%)     34 (33.3%)      79 (26.2%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  37 (38.1%)   44 (42.7%)     43 (42.2%)     124 (41.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd A.1.1.1.1                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       42 (43.3%)    36 (35%)      54 (52.9%)     132 (43.7%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MILD                    42 (43.3%)    36 (35%)      54 (52.9%)     132 (43.7%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd A.1.1.1.2                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       37 (38.1%)   44 (42.7%)     43 (42.2%)     124 (41.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                37 (38.1%)   44 (42.7%)     43 (42.2%)     124 (41.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl B.2                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         59 (60.8%)   59 (57.3%)     73 (71.6%)     191 (63.2%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MILD                      23 (23.7%)   22 (21.4%)     28 (27.5%)      73 (24.2%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  36 (37.1%)   37 (35.9%)     45 (44.1%)     118 (39.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd B.2.2.3.1                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       38 (39.2%)   42 (40.8%)     42 (41.2%)     122 (40.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MILD                    38 (39.2%)   42 (40.8%)     42 (41.2%)     122 (40.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd B.2.1.2.1                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       36 (37.1%)   37 (35.9%)     45 (44.1%)     118 (39.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                36 (37.1%)   37 (35.9%)     45 (44.1%)     118 (39.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl D.1                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         60 (61.9%)   56 (54.4%)     67 (65.7%)     183 (60.6%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  20 (20.6%)   24 (23.3%)     24 (23.5%)      68 (22.5%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   SEVERE                    40 (41.2%)   32 (31.1%)     43 (42.2%)     115 (38.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd D.1.1.1.1                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       40 (41.2%)   32 (31.1%)     43 (42.2%)     115 (38.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     SEVERE                  40 (41.2%)   32 (31.1%)     43 (42.2%)     115 (38.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd D.1.1.4.2                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       37 (38.1%)   37 (35.9%)     41 (40.2%)     115 (38.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                37 (38.1%)   37 (35.9%)     41 (40.2%)     115 (38.1%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl D.2                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         35 (36.1%)   50 (48.5%)      49 (48%)      134 (44.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MILD                      35 (36.1%)   50 (48.5%)      49 (48%)      134 (44.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd D.2.1.5.3                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       35 (36.1%)   50 (48.5%)      49 (48%)      134 (44.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MILD                    35 (36.1%)   50 (48.5%)      49 (48%)      134 (44.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl B.1                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         37 (38.1%)   40 (38.8%)     36 (35.3%)     113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   SEVERE                    37 (38.1%)   40 (38.8%)     36 (35.3%)     113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd B.1.1.1.1                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       37 (38.1%)   40 (38.8%)     36 (35.3%)     113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     SEVERE                  37 (38.1%)   40 (38.8%)     36 (35.3%)     113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl C.2                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -         26 (26.8%)   38 (36.9%)      49 (48%)      113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   MODERATE                  26 (26.8%)   38 (36.9%)      49 (48%)      113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd C.2.1.2.1                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -       26 (26.8%)   38 (36.9%)      49 (48%)      113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     MODERATE                26 (26.8%)   38 (36.9%)      49 (48%)      113 (37.4%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> cl C.1                                                                             </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   - Any Intensity -          32 (33%)    38 (36.9%)     35 (34.3%)     105 (34.8%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   SEVERE                     32 (33%)    38 (36.9%)     35 (34.3%)     105 (34.8%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>   dcd C.1.1.1.3                                                                    </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     - Any Intensity -        32 (33%)    38 (36.9%)     35 (34.3%)     105 (34.8%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     SEVERE                   32 (33%)    38 (36.9%)     35 (34.3%)     105 (34.8%) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ———————————————————————————————————————————————————————————————————————————————————</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Investigator text for AEs encoded using MedDRA version xx.x.  All counts represent patients. Multiple occurrences of the same AE in one individual are counted once at the greatest intensity for this preferred term. To the SOC Overall row counts, a patient contributes only with the AE occuring with the greatest intensity within the SOC. Standard footnote defining AEs included in table (e.g., includes AEs with onset from first dose of study drug through 7 days after last dose of study drug).</span>
<span class='r-in'><span class='fu'>aet03_1_lyt</span><span class='op'>(</span></span>
<span class='r-in'>  armvar <span class='op'>=</span> <span class='st'>"ACTARM"</span>,</span>
<span class='r-in'>  lbl_AEBODSYS <span class='op'>=</span> <span class='st'>"Body System or Organ Class"</span>,</span>
<span class='r-in'>  lbl_AEDECOD <span class='op'>=</span> <span class='st'>"Dictionary-Derived Term"</span>,</span>
<span class='r-in'>  lbl_overall <span class='op'>=</span> <span class='cn'>NULL</span>,</span>
<span class='r-in'>  deco <span class='op'>=</span> <span class='fu'><a href='std_deco.html'>std_deco</a></span><span class='op'>(</span><span class='st'>"AET03"</span><span class='op'>)</span></span>
<span class='r-in'><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> A Pre-data Table Layout</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Column-Split Structure:</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> ACTARM (lvls) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Row-Split Structure:</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> AEBODSYS (lvls) -&gt; AEDECOD (lvls) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
</pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by NEST, Roche, Adrian Waddell, Benoit Falquet.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.6.1.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


